Kaplan-Meier survival curves for the low hs-CRP group (≤1.96 mg/L) and the high hs-CRP group (>1.96 mg/L) in patients with cardiovascular disease.

<p>Overall survival rates (A), progression-free survival rates (B), locoregional relapse-free survival (C) and distant metastasis-free survival rates (D) were compared in the subgroup of NPC patients with cardiovascular disease. Hazards ratios (HRs) were calculated using the unadjusted Cox proportional hazards model. P values were calculated using the unadjusted log-rank test.